The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.
 
Joyce F. Liu
No Relationships to Disclose
 
Mark F. Brady
No Relationships to Disclose
 
Ursula A. Matulonis
No Relationships to Disclose
 
Austin Miller
No Relationships to Disclose
 
Elise C. Kohn
No Relationships to Disclose
 
Elizabeth M. Swisher
No Relationships to Disclose
 
William P. Tew
No Relationships to Disclose
 
Noelle Gillette Cloven
No Relationships to Disclose
 
Carolyn Muller
No Relationships to Disclose
 
David Bender
No Relationships to Disclose
 
Richard G. Moore
No Relationships to Disclose
 
David Paul Michelin
No Relationships to Disclose
 
Steven E. Waggoner
No Relationships to Disclose
 
Melissa Ann Geller
No Relationships to Disclose
 
Keiichi Fujiwara
No Relationships to Disclose
 
Stacy D. D'Andre
No Relationships to Disclose
 
Michael Carney
No Relationships to Disclose
 
Angeles Alvarez Secord
No Relationships to Disclose
 
Katherine M. Moxley
No Relationships to Disclose
 
Michael A. Bookman
No Relationships to Disclose